BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10855999)

  • 21. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; HernĂ¡n MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of palliative care into primary care for human immunodeficiency virus-infected patients.
    Kutzen HS
    Am J Med Sci; 2004 Jul; 328(1):37-47. PubMed ID: 15254440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuing debate over HIV therapy initiation.
    Idemyor V
    HIV Clin Trials; 2002; 3(2):173-6. PubMed ID: 11976997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern of linkage and retention in HIV care continuum among patients attending referral HIV care clinic in private sector in India.
    Parchure R; Kulkarni V; Kulkarni S; Gangakhedkar R
    AIDS Care; 2015; 27(6):716-22. PubMed ID: 25559639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of children with advanced HIV initiated on antiretroviral therapy in a South African hospice.
    Brits H; Joubert G
    Int J Palliat Nurs; 2015 Jun; 21(6):281-6. PubMed ID: 26126676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.
    Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS and the long term care continuum.
    Wyatt A
    Pride Inst J Long Term Home Health Care; 1990; 9(1):6-14. PubMed ID: 10113174
    [No Abstract]   [Full Text] [Related]  

  • 30. Part XV. Antiretroviral therapy for human immunodeficiency virus infection.
    Stephens JR; Rathbun RC; Lockhart SM; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Nov; 100(11):417-24. PubMed ID: 18183858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status and future issues in the treatment of HIV-1 infection.
    Matsushita S
    Int J Hematol; 2000 Jul; 72(1):20-7. PubMed ID: 10979204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing the care of minority patients with HIV/AIDS.
    Stone VE
    Clin Infect Dis; 2004 Feb; 38(3):400-4. PubMed ID: 14727211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.
    Arici C; Ripamonti D; Ravasio V; Maggiolo F; Rizzi M; Finazzi MG; Suter F
    Int J STD AIDS; 2001 Sep; 12(9):573-81. PubMed ID: 11516366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taking HAART. How to support patients with HIV/AIDS.
    Jones SG
    Nursing; 2001 Dec; 31(12):36-41; quiz 42. PubMed ID: 11921714
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in HIV/AIDS therapy.
    Johnson SC; Gerber JG
    Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Delayed virus suppression has its price. Heart and liver are no longer secondary theaters].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():12-4. PubMed ID: 12043063
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-Term suppression of HIV infection: benefits and limitations of current treatment options.
    Sension MG
    J Assoc Nurses AIDS Care; 2007; 18(1 Suppl):S2-10. PubMed ID: 17275719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [AIDS--past, present and future].
    Levy I; Shasha D; Grossman Z
    Harefuah; 2011 Mar; 150(3):246-50, 304, 303. PubMed ID: 21574358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges in providing comprehensive and coordinated care to HIV/AIDS patients: a Canadian perspective.
    Tsasis P
    Healthc Manage Forum; 2000; 13(1):43-9. PubMed ID: 10947429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.